Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2

Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.

Guardado en:
Detalles Bibliográficos
Autores principales: Reiter, Russel J., Cardinali, Daniel Pedro, Neel, Richard L., Domínguez Rodriguez, Alberto, Brown, Gregory M., Tesarik, Jan
Formato: Artículo
Lenguaje:Inglés
Publicado: ST-Bio-Life LLC 2022
Materias:
Acceso en línea:https://repositorio.uca.edu.ar/handle/123456789/13671
Aporte de:
id I33-R139123456789-13671
record_format dspace
institution Universidad Católica Argentina
institution_str I-33
repository_str R-139
collection Repositorio Institucional de la Universidad Católica Argentina (UCA)
language Inglés
topic MELATONINA
SARS-CoV-19
VARIANTE DELTA COVID-19
VARIANTES FUTURAS
spellingShingle MELATONINA
SARS-CoV-19
VARIANTE DELTA COVID-19
VARIANTES FUTURAS
Reiter, Russel J.
Cardinali, Daniel Pedro
Neel, Richard L.
Domínguez Rodriguez, Alberto
Brown, Gregory M.
Tesarik, Jan
Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
topic_facet MELATONINA
SARS-CoV-19
VARIANTE DELTA COVID-19
VARIANTES FUTURAS
description Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.
format Artículo
author Reiter, Russel J.
Cardinali, Daniel Pedro
Neel, Richard L.
Domínguez Rodriguez, Alberto
Brown, Gregory M.
Tesarik, Jan
author_facet Reiter, Russel J.
Cardinali, Daniel Pedro
Neel, Richard L.
Domínguez Rodriguez, Alberto
Brown, Gregory M.
Tesarik, Jan
author_sort Reiter, Russel J.
title Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
title_short Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
title_full Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
title_fullStr Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
title_full_unstemmed Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2
title_sort rationale for the continued use of melatonin to combat the delta variant of sars-cov-2
publisher ST-Bio-Life LLC
publishDate 2022
url https://repositorio.uca.edu.ar/handle/123456789/13671
work_keys_str_mv AT reiterrusselj rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2
AT cardinalidanielpedro rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2
AT neelrichardl rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2
AT dominguezrodriguezalberto rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2
AT browngregorym rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2
AT tesarikjan rationaleforthecontinueduseofmelatonintocombatthedeltavariantofsarscov2
bdutipo_str Repositorios
_version_ 1764820526390312960